Sonographically guided 11-G directional vacuum-assisted breast biopsy as an alternative to surgical excision: utility and cost study in probably benign lesions
Alonso-Bartolomé P., Vega-Bolivar A., Tores-Tabanera M., Ortega E., Acebal-Blanco M., Garijo-Ayensa F., rodrigo I., Muńoz-Cacho P., Acta Radiol 2004, 45: 390-396
To evalute the utility and economic costs of the 11-G vacuum-assisted biopsy probe under ultrasound (US) guidance as an alternative to surgical excision in patients with probably benign lesions.
Comparison of automated versus vacuum-assisted biopsy methods for sonographically guided core biopsy of the breast
Philpotts L. E. , Hooley R. J. , Lee C. H.
Presented at the annual meeting of the American Roentgen Ray Society, Atlanta, April-May 2002.
Objective: The purpose of this study was to compare the outcome of sonographically guided core biopsies performed with the 14-gauge automated gun with the outcome of those performed with the 11-gauge vacuum-assisted device. Outcome was defined in terms of missed tumors, the need (both immediate and delayed) for a second biopsy, histologic underestimation, and complication rates.
Nonmalignant lesions in breast core. To excise or not to excise?
Jacobs T. W., Connolly J. L., M.D:, Schnitt S. J., MD, The American Journal of Surgical Pathology 2002, 26 (9): 1095–1110
Large core needle biopsies using stereotaxic mammography or ultrasound guidance are now commonly performed as the initialdiagnostic approach to nonpalpable breast lesion. Althought the subsequent management of petients with invasive cancer, ductal carcinoma in situ, and most benign lesiondiagnosed on core needlebiopsy specimens is straightforward, certain nonmalignant lesion pose dilemmas with regard to the most appropriate clinical management following core needle biopsy.
Fibroadenomas of the breast: is there any association with breast cancer?
Markopoulos C., Kouskos E., Mantas D., Kontzoglou K., Antonopoulou Z., Revanas K., Kyriakou V., Eur. J .Gynacc. Oncol. 2004
The experience of our Breast Unit in the diagnosis and treatment of fibroadenomas is presented in this retrospect study, focusing specifically in cancer development within these common beningn tumors of young age.
Single dilated lactiferous duct due to papilloma ultrasonographically guided percutaneous biopsy with a vacuum-assisted device
March D. E. , MD, Coughlin B. F., MD, Polino J. R. , MD, Goulart R. A. , MD, Makari-Judson G., MD, J. Ultrasound. Med. 2002 21:107–111
The appearance of a solitary dilated duct on mammography may be the sole indication of breastmalignancy. This finding has a low positive predictive value for carcinoma3 and was the most important abnormality prompting biopsy in only 4 of 300 consecutive nonpalpable breast cancers reported by Sickles. Unilateral dilated ducts on mammography are most often due to benign processes but may be indications for biopsy if the finding is new or progressive, in a nonsubareolar location, or associated with indeterminate calcifications.
Breast masses: removal of all US evidence during biopsy by using a handheld vacuum-assisted device - initial experience
March D. E. , MD, Coughlin B. F., MD, Barham R. B. , MPH., Goulart R. A.,MD, Klein S. V., MD, Bur M.E. , MD, Frank J. L., MD, Makari-Judson G., MD, Radiology 2003, 227:549–555
To assess the effects of removal of all ultrasonographic (US) evidence of breast lesions by using a vacuum-assisted biopsy (VAB) device.
Low-risk palpable breast masses removed using a vacuum-assisted hand-held device
Fine R. E., MD, Whitworth P. W., MD, Kim J. A. , MD, Harness J. K. , MD, Boyd B. A. , RN, Burak W. E. Jr., MD, The American Journal of Surgery 2003, 186: 362–367
This study evaluates the safety, efficacy, and patient acceptance of a vacuum-assisted, hand-held biopsy device (Mammatome) in the percutaneous removal of breast masses using ultrasound guidance.
Cryoablation of benign breast tumors: evolution of technique and technology
Caleffi M., Duarte Filho D., Borghetti K., Graudenz M., Littrup P. J., Freeman-Gibb L. A., Zannis V. J., Schultz M. J., Kaufman C. S., Francesscatti D., Smith J. S., Simmons R., Bailey L., Henry C. A., Stocks L. H., The Breast 2004, 13: 397–407
We report on improvements in cryoprobe design and techniques of cryoablation as a minimally invasive alternative to open surgery for the treatmentof benign breast tumors. In the study, wich was conducted in 12 centers, 124 lesions in 102 patients were monitored for a period of 12 months after cryoablation.
Minimal invasive complete excision of benign breast tumors using a three-dimensional ultrasound-guided mammotome vacuum device
Baez E., Huber A., Vetter M., Hackelöer B. J., Ultrasound Obstet Gynecol 2003, 21: 267–272
The aim of this study was to evaluate the use of three-dimensional (3D) ultrasonography in the complete excision of benign breast tumors using ultrasound-guided vacuum-assisted core-needle biopsy (Mammotome®). A protocol for the management of benign breast tumors is proposed.
Ultrasound guided minimally invasive breast surgery (UMIBS). A superior technique for gynecomastia
Iwuagwu O. C. , Calvey T. A. J., Ilsley D., Drew P. J., Annals of Plastic Surgery, Volume 52, Number 2, February 2004
The last 30 years has seen a shift in surgical treatment of breast diseases to less invasive, more conservative treatment options. The mammotome equipment was originally introduced as a diagnostic tool, but advances in technology have extended its role to therapeutic procedures. The mammotome device (8-gauge) is inserted through a cosmetically placed 4-mm scar and breast tissue is resected sequentially using a suction facility without the need to remove the biopsy device.
Papillomas and atypical papillomas in breast core needle biopsy specimens. Risk of carcinoma in subsequent excision
Renshaw A. A., Derhagopian R. P., Tizol-Blanco D. M., Gould E. W., Am. J. Clin. Pathol. 2004, 122: 217–221
We sought to define the risk associated with papillomas and atypical papillomas in breast core needle biopsy specimens from a series of approximately 8,500 biopsies performed during 8 years.
Solid breast nodules: use of sonography to distinguish between benign and malignant lesions
Stavros A. T., Thickman D., Rapp C. L., Dennis M. A., Parker S. H., Sisney G. A., Radiology 1995, Volume 196, 1: 123–134
To determine whether sonography could help accurately distinguish benign solid breast nodules from indeterminate or malignant nodules and whether this distinction could be definite enough to obviate biopsy.
Diagnosis and treatment of breast fibroadenomas by ultrasound-guided vacuum-assisted biopsy
Sperber F., Blank A., Metser U., Flusser G., Klausner J. M., Chelouche D. L., Arch. Surg. 2003, 138: 796–800
Fibroadenoma is the most common breast tumor in adolescent girls and women younger than 25 years. Although the peak incidence is between the second and third decades of life, it is not uncommon in postmenopausal women, with an increased incidence after hormone replacement therapy.
Sonographically guided directional vacuum-assisted breast biopsy using a handheld device
Parker S. H., Klaus A. J., Mc Wey P. J., Schilling K. J., Cupples T. E., Duchesne N., Guenin M. A., Harness J. K., AJR 2001, 177
The goal this study was to show that one can safely remove all sonographic evidence of masses in the breast less than or equel to 1.5 cm in greates dimension using the 11-gauge handheld Mammotome, thereby reducing the possibility of a false-negative diagnosis and other shortcomings of the automated core biopsy device.